Assessment of Interleukin-21 Gene Polymorphisms and Protein Level in Rheumatoid Arthritis among Egyptians
DOI:
https://doi.org/10.3889/oamjms.2025.12003Keywords:
IL-21, rheumatoid arthritis, polymorphism, SNP, EgyptiansAbstract
BACKGROUND: Rheumatoid Arthritis (RA) is characterized by joint damage, persistent inflammation, and producing autoantibodies. Interleukin 21 (IL-21) and its receptor (IL 21R) have an important function in the pathogenesis of RA. High serum level of IL-21 has been related to RA and disease activity.
AIM: Here, we assessed the relationship of IL-21 polymorphisms and IL-21 serum levels with RA among Egyptians.
METHODS: DNA was separated from peripheral blood of 120 healthy controls and 120 patients with RA and genotyped for two single nucleotide polymorphisms of the IL-21 gene (rs2055979 and rs2221903) using polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) technique. IL-21 serum level was assessed by ELISA.
RESULTS: The IL-21 rs2055979 AA genotype and A allele were higher in RA patients than in the control group (p =0.005, OR=2.657, 95% CI=1.333-5.293 and p =0.019, OR=1.932, 95% CI=1.112-3.356 respectively). The serum levels of anti-CCP, IL-21, Rheumatoid factor, C-reactive protein and ESR were higher in RA subjects in comparison to the controls (p <0.0001). Furthermore, IL-21 serum level was higher in AA genotype of RA patients in comparison to the CC and CA genotypes (p <0.001 and 0.041 respectively). The IL21 rs2221903 genotypes and alleles were statistically indifferent between the studied groups.
CONCLUSIONS: IL-21 rs2255979 polymorphism is associated with the susceptibility to RA in Egyptian subjects. Moreover, the elevated IL-21 levels and its association with AA genotype in RA patients indicate its importance in the pathogenesis of RA. This means that IL-21 might be used as genetic marker and would have therapeutic application in RA.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Smolen, J.S.; Aletaha, D.; McInnes, I.B. Rheumatoid arthritis. Lancet 2016, 388, 2023-2038. https://doi.org/10.1016/S0140-6736(16)30173-8 PMid:27156434
Firestein, G.S. (2003) Evolving concepts of rheumatoid arthritis. Nature 423, 356-361, https://doi.org/10.1038/nature01661 PMid:12748655
Shikhagaie, M.M., Germar, K., Bal, S.M., Ros, X.R. and Spits, H. (2017) Innate lymphoid cells in autoimmunity: emerging regulators in rheumatic diseases. Nat. Rev. Rheumatol. 13, 164-173, https://doi.org/10.1038/nrrheum.2016.218 PMid:28148916
Spolski R, Leonard WJ. Interleukin-21: a double-edged sword with therapeutic potential. Nat Rev Drug Discov. 2014;13(5):379-95. https://doi.org/10.1038/nrd4296 PMid:24751819
Xing, R.; Sun, L.;Wu, D.; Jin, Y.; Li, C.; Liu, X.; Zhao, J. Autoantibodies against interleukin-21 correlate with disease activity in patients with rheumatoid arthritis. Clin. Rheumatol. 2018, 37, 75-80. https://doi.org/10.1007/s10067-017-3862-8 PMid:29019047
Jungel A, Distler JH, Kurowska-Stolarska M, Seemayer CA, Seibl R, Forster A, Michel BA, Gay RE, Emmrich F, Gay S, et al. Expression of interleukin-21 receptor, but not interleukin-21, in synovial fibroblasts and synovial macrophages of patients with rheumatoid arthritis. Arthritis Rheum. 2004;50(5):1468-76. https://doi.org/10.1002/art.20218 PMid:15146416
Kwok SK, Cho ML, Park MK, Oh HJ, Park JS, Her YM, Lee SY, Youn J, Ju JH, Park KS, et al. Interleukin-21 promotes osteoclastogenesis in humans with rheumatoid arthritis and in mice with collagen-induced arthritis. Arthritis Rheum. 2012;64(3):740-51. https://doi.org/10.1002/art.33390 PMid:21968544
Parrish-Novak, J.; Dillon, S.R.; Nelson, A.; Hammond, A.; Sprecher, C.; Gross, J.A.; Johnston, J.; Madden, K.; Xu, W.; West, J.; et al. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 2000, 408, 57-63. https://doi.org/10.1038/35040504 PMid:11081504
Dinesh, P.; Rasool, M. Multifaceted role of IL-21 in rheumatoid arthritis: Current understanding and future perspectives. J. Cell. Physiol. 2018, 233, 3918-3928. https://doi.org/10.1002/jcp.26158 PMid:28833093
Malinowski, D.; Paradowska-Gorycka, A.; Safranow, K.; Pawlik, A. Interleukin-21 gene polymorphism rs2221903 is associated with disease activity in patients with rheumatoid arthritis. Arch. Med. Sci. AMS 2017, 13, 1142-1147. https://doi.org/10.5114/aoms.2017.68945 PMid:28883856 PMCid:PMC5575225
Gharibi, T.; Kazemi, T.; Aliparasti,M.R.; Farhoudi,M.; Almasi, S.; Dehghanzadeh, R.; Seyfizadeh, N.; Babaloo, Z. Investigation of IL-21 gene polymorphisms (rs2221903, rs2055979) in cases with multiple sclerosis of Azerbaijan, Northwest Iran. Am. J. Clin. Exp. Immunol. 2015, 4, 7-14.
Lan, Y.; Luo, B.; Wang, J.L.; Jiang, Y.W.; Wei, Y.S. The association of interleukin-21 polymorphisms with interleukin-21 serum levels and risk of systemic lupus erythematosus. Gene 2014, 538, 94-98. Genes 2023, 14, 878 12 of 12. https://doi.org/10.1016/j.gene.2014.01.012PMid:24434811
Zhang, J.; Xiao, W.X.; Zhu, Y.F.; Muhali, F.S.; Xiao, L.; Jiang, W.J.; Shi, X.H.; Zhou, L.H.; Zhang, J.A. Polymorphisms of interleukin- 21 and interleukin-21-receptor genes confer risk for autoimmune thyroid diseases. BMC Endocr. Disord. 2013, 13, 26. https://doi.org/10.1186/1472-6823-13-26 PMid:23889847 PMCid:PMC3766107
Carreño-Saavedra NM, Reyes-Pérez IV, Machado-Sulbaran AC, Martínez-Bonilla GE, Ramírez-Dueñas MG, Muñoz-Valle JF, Olaya-Valdiviezo V, García-Iglesias T, Martínez-García EA, Sánchez-Hernández PE.Genes (Basel). IL-21 (rs2055979 and rs2221903)/IL-21R (rs3093301) Polymorphism and High Levels of IL-21 Are Associated with Rheumatoid Arthritis in Mexican Patients.2023 Apr 7;14(4):878. https://doi.org/10.3390/genes14040878 PMid:37107636 PMCid:PMC10137781
Hao Y, Xie L, Xia J, Liu Z, Yang B, Zhang M.BMC Musculoskelet Disord. Plasma interleukin-21 levels and genetic variants are associated with susceptibility to rheumatoid arthritis 2021 Mar 5;22(1):246. https://doi.org/10.1186/s12891-021-04111-0 PMid:33673829 PMCid:PMC7936495
Daha NA, Kurreeman FA, Marques RB, Stoeken-Rijsbergen G, Verduijn W, Huizinga TW, Toes RE. Confirmation of STAT4, IL2/IL21, and CTLA4 polymorphisms in rheumatoid arthritis. Arthritis Rheum. 2009;60(5):1255-60. https://doi.org/10.1002/art.24503 PMid:19404967
Maiti AK, Kim-Howard X, Viswanathan P, Guillén L, Rojas-Villarraga A, Deshmukh H, Direskeneli H, Saruhan-Direskeneli G, Cañas C, Tobön GJ, et al. Confirmation of an association between rs6822844 at the Il2-Il21 region and multiple autoimmune diseases: evidence of a general susceptibility locus. Arthritis Rheum. 2010;62(2):323-9. https://doi.org/10.1002/art.27222 PMid:20112382 PMCid:PMC3028384
Louahchi S, Allam I, Raaf N, Berkani L, Boucharef A, Abdessemed A, Khaldoun N, Bahaz N, Ladjouze-Rezig A, Nebbab A, et al. Association of rs6822844 within the KIAA1109/TENR/IL2/IL21 locus with rheumatoid arthritis in the Algerian population. Hla. 2016;87(3):160-4. https://doi.org/10.1111/tan.12757 PMid:26917059
Ibrahim ME, Shahba AAEM, Mohamed WS, Hazza SME. Interleukin -21 gene RS 2221903 polymorphisms in rheumatoid arthritis patients. IJARM 2023; 5(2): 09-17. https://doi.org/10.22271/27069567.2023.v5.i2a.472
Abdelsamea SA, Khashaba RA, Amer AS, khalifa OA, Ameen SG. A study of the Association between Plasma Interleukin-21 Gene Polymorphism and the Susceptibility to Rheumatoid Arthritis in Egyptian Patients. Benha Medical Journal 2024;41(1):94-100. https://doi.org/10.21608/bmfj.2024.265553.2004
Felson DT, Anderson JJ, Boers M, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum 1993; 36: 729-40. https://doi.org/10.1002/art.1780360601 PMid:8507213
Humphreys JH, Symmons DP. Post publication validation of the 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: where do we stand? Curr Opin Rheumatol 2013; 25: 157-63. https://doi.org/10.1097/BOR.0b013e32835cfc41 PMid:23274519
Trouw, L.A., Pickering, M.C. and Blom, A.M. (2017) The complement system as a potential therapeutic target in rheumatic disease. Nat. Revi. Rheumatol. 2017;13, 538-547. https://doi.org/10.1038/nrrheum.2017.125 PMid:28794515
J. Kurkó, T. Besenyei, J. Laki, T. T. Glant, K. Mikecz, and Z. Szekanecz, "Genetics of rheumatoid arthritis-a comprehensive review," Clinical Reviews in Allergy and Immunology. 2013; 45 (2), 170-179. https://doi.org/10.1007/s12016-012-8346-7 PMid:23288628 PMCid:PMC3655138
G. J. Tobon, P. Youinou, and A. Saraux, "The environment, geo-epidemiology, and autoimmune disease: rheumatoid arthritis," Journal of Autoimmunity. 2010; 35(1), 10-14. https://doi.org/10.1016/j.autrev.2009.11.019 PMid:19944780
S. Viatte, D. Plant, and S. Raychaudhuri, "Genetics and epigenetics of rheumatoid arthritis," Nature Reviews Rheumatology. 2013;9(3),141-153. https://doi.org/10.1038/nrrheum.2012.237 PMid:23381558 PMCid:PMC3694322
McInnes, I.B. and Schett, G. Pathogenetic insights from the treatment of rheumatoid arthritis. Lancet (London, England). 2017;389, 2328-2337. https://doi.org/10.1016/S0140-6736(17)31472-1 PMid:28612747
Yuan, F.L., Hu, W., Lu, W.G., Li, X., Li, J.P., Xu, R.S. et al. Targeting interleukin-21 in rheumatoid arthritis. Mol. Biol. Rep. 2011; 38, 1717-1721. https://doi.org/10.1007/s11033-010-0285-x PMid:20848219
Kwok, S.K., Cho, M.L., Park, M.K., Oh, H.J., Park, J.S., Her, Y.M. et al. (2012) Interleukin-21 promotes osteoclastogenesis in humans with rheumatoid arthritis and in mice with collagen-induced arthritis. Arthritis Rheum. 64, 740-751. https://doi.org/10.1002/art.33390 PMid:21968544
Xing, R., Jin, Y., Sun, L., Yang, L., Li, C., Li, Z. et al. (2016) Interleukin-21 induces migration and invasion of fibroblast-like synoviocytes from patients with rheumatoid arthritis. Clin. Exp. Immunol. 184, 147-158. https://doi.org/10.1111/cei.12751 PMid:26646950 PMCid:PMC4837236
Lubberts, E. (2010) Th17 cytokines and arthritis. Seminars in Immunopathol. 32, 43-53, https://doi.org/10.1007/s00281-009-0189-9 PMid:20127485 PMCid:PMC2836464
Leonard WJ, Wan C-K. IL-21 Signaling in Immunity. F1000Research. 2016;5: F1000 Faculty Rev-1224. https://doi.org/10.12688/f1000research.7634.1 PMid:26966515 PMCid:PMC4770986
Sauna, Z.E.; Kimchi-Sarfaty, C. Understanding the contribution of synonymous mutations to human disease. Nat. Reviews. Genet. 2011, 12, 683-691. https://doi.org/10.1038/nrg3051 PMid:21878961
Reyes-Perez, I.V.; Sanchez-Hernandez, P.E.; Munoz-Valle, J.F.; Martinez-Bonilla, G.E.; Garcia-Iglesias, T.; Gonzalez-Diaz, V.; Garcia-Arellano, S.; Cerpa-Cruz, S.; Polanco-Cruz, J.; Ramirez-Duenas, M.G. Cytokines (IL-15, IL-21, and IFN-) in rheumatoid arthritis: Association with positivity to autoantibodies (RF, anti-CCP, anti-MCV, and anti-PADI4) and clinical activity. Clin. Rheumatol. 2019, 38, 3061-3071. https://doi.org/10.1007/s10067-019-04681-4 PMid:31312989
Wu, Y.; van Besouw, N.M.; Shi, Y.; Hoogduijn, M.J.; Wang, L.; Baan, C.C. The Biological Effects of IL-21 Signaling on B-Cell-Mediated Responses in Organ Transplantation. Front. Immunol. 2016, 7, 319. https://doi.org/10.3389/fimmu.2016.00319
Lan Y, Luo B, Wang JL, Jiang YW, Wei YS. The association of interleukin 21 polymorphisms with interleukin 21 serum levels and risk of systemic lupus erythematosus. Gene. 2014 Mar 15;538(1):94-8. https://doi.org/10.1016/j.gene.2014.01.012 PMid:24434811
Espinoza-García N, Salazar-Camarena DC, Marín-Rosales M, Reyes-Mata MP, Ramírez-Dueñas MG, Muñoz-Valle JF, Borunda-Calderón IM, González-Palacios A, Palafox-Sánchez CA. High Interleukin 21 Levels in Patients with Systemic Lupus Erythematosus: Association with Clinical Variables and rs2221903 Polymorphism. J Clin Med. 2024 Aug 2;13(15):4512. https://doi.org/10.3390/jcm13154512 PMid:39124778 PMCid:PMC11313274
Ding L, Wang S, Chen GM, Leng RX, Pan HF, Ye DQ. A single nucleotide polymorphism of IL-21 gene is associated with systemic lupus erythematosus in a Chinese population. Inflammation. 2012;35(6):1781-5. https://doi.org/10.1007/s10753-012-9497-7 PMid:22752563
Xing R, Sun L, Wu D, Jin Y, Li C, Liu X, Zhao J. Autoantibodies against interleukin-21 correlate with disease activity in patients with rheumatoid arthritis. Clin Rheumatol. 2018;37(1):75-80. https://doi.org/10.1007/s10067-017-3862-8 PMid:29019047
Downloads
Published
How to Cite
License
Copyright (c) 2025 Fathy M. Elfasakhany, Mashael S. Alqahtani, Ahmed F. Elfasakhany, Ayman M. A. Elguindy (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0)
